Efficacy and safety of quercetin and polyvinylpyrrolidone in treatment of patients with newly diagnosed destructive pulmonary tuberculosis in comparison with standard antimycobacterial therapy

被引:15
|
作者
Butov, Dmytro [1 ]
Zaitseva, Svetlana [1 ]
Butova, Tatyana [2 ]
Stepanenko, Ganna [1 ]
Pogorelova, Olga [1 ]
Zhelezniakova, Natalia [2 ]
机构
[1] Kharkiv Natl Med Univ, Dept Phthisiol & Pulmonol, 4 Prospekt Nauky, UA-61022 Kharkov, Ukraine
[2] Kharkiv Natl Med Univ, Dept Internal Med N1, Kharkov, Ukraine
关键词
Immunotherapy; Quercetin; Quercetin and polyvinylpyrrolidone; Treatment of tuberculosis; Tuberculosis;
D O I
10.1016/j.ijmyco.2016.06.012
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective/background: The objective/background of this work was to study the efficacy and safety of quercetin and polyvinylpyrrolidone (QP) in the treatment of patients with newly diagnosed destructive pulmonary tuberculosis in comparison with standard antimycobacterial therapy. Materials and methods: The study involved 124 patients aged between 20 years and 70 years with newly diagnosed destructive pulmonary tuberculosis. Patients were allocated to two groups. The first (control) group of patients received standard antimycobacterial and pathogenetic therapy and included 31 (25.00 +/- 3.89%) patients. The second (main) group of patients received QP therapy in addition to chemotherapy and included 93 (75.00 +/- 3.89%) patients. Results: Intoxication symptoms in the second group were reduced following 1.33 +/- 0.15 months, whereas in the first group intoxication symptoms were reduced following 2.64 +/- 0.20 months, p < .001. Conclusion: Administration of QP combined with chemotherapy in patients with newly diagnosed destructive pulmonary tuberculosis resulted in a comparatively quick reduction of disease manifestation. (C) 2016 Asian-African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
引用
收藏
页码:446 / 453
页数:8
相关论文
共 50 条
  • [21] Safety and efficacy of FLAG-Ida-based therapy combined with venetoclax for the treatment for newly diagnosed and relapsed/refractory patients with AML - A systematic review
    Sherban, A.
    Fredman, D.
    Shimony, S.
    Yeshurun, M.
    Raanani, P.
    Stahl, M.
    Gafter-Gvili, A.
    Wolach, O.
    LEUKEMIA RESEARCH, 2023, 133
  • [22] Safety and Efficacy of FLAG-IDA-Based Therapy Combined With Venetoclax for the Treatment of Newly Diagnosed and Relapsed/Refractory Patients With AML: A Systematic Review
    Sherban, Adi
    Fredman, Danielle
    Shimony, Shai
    Yeshurun, Moshe
    Raanani, Pia
    Stahl, Maximillian
    Gafter-Gvili, Anat
    Wolach, Ofir
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S264 - S264
  • [23] The Efficacy and Safety of Surgical Treatment for Patients With Tuberculosis Destroyed Lung With or Without Chronic Pulmonary Aspergillosis
    Hongyun Ruan
    Changfan Gong
    Jinxiang Wang
    World Journal of Surgery, 2021, 45 : 1595 - 1601
  • [24] The Efficacy and Safety of Surgical Treatment for Patients With Tuberculosis Destroyed Lung With or Without Chronic Pulmonary Aspergillosis
    Ruan, Hongyun
    Gong, Changfan
    Wang, Jinxiang
    WORLD JOURNAL OF SURGERY, 2021, 45 (05) : 1595 - 1601
  • [25] The Efficacy and Safety of Bedaquiline in the Treatment of Pulmonary Tuberculosis Patients: A Systematic Review and Meta-Analysis
    Tong, Enyu
    Wu, Qian
    Chen, Yiming
    Liu, Zhengwei
    Zhang, Mingwu
    Zhu, Yelei
    Wu, Kunyang
    Pan, Junhang
    Jiang, Jianmin
    ANTIBIOTICS-BASEL, 2023, 12 (09):
  • [26] Comparison of the safety and efficacy of a fixed-dose combination regimen and separate formulations for pulmonary tuberculosis treatment
    Wu, Jiun-Ting
    Chiu, Chien-Tung
    Wei, Yu-Feng
    Lai, Yung-Fa
    CLINICS, 2015, 70 (06) : 429 - 434
  • [27] A RANDOMIZED PHASE II TRIAL TO COMPARE THE EFFICACY OF STANDARD VERSUS COMBINATION THERAPY (PERAMPANEL, MEMANTINE PLUS STANDARD) IN THE TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED GBM-A STUDY DESIGN
    Kong, Xiao-Tang
    Albala, Bruce
    Du, Senxi
    Kong, Xiao-Tang
    Bota, Daniela
    NEURO-ONCOLOGY, 2020, 22 : 194 - 194
  • [28] Efficacy and safety of oxcarbazepine as monotherapy or adjunctive therapy in adolescent patients with newly diagnosed or uncontrolled seizures: A meta-analysis
    Schwabe, S
    Somogyi, M
    McCague, K
    D'souzo, J
    EPILEPSIA, 2005, 46 : 202 - 202
  • [29] Impact of nicotine replacement therapy as an adjunct to anti-tuberculosis treatment and behaviour change counselling in newly diagnosed pulmonary tuberculosis patients: an open-label, randomised controlled trial
    Sharma, Surendra Kumar
    Mohan, Alladi
    Singh, Achintya Dinesh
    Mishra, Hridesh
    Jhanjee, Sonali
    Pandey, Ravindra Mohan
    Singh, Binit Kumar
    Sharma, Rohini
    Pallipamu, Prakash Babu
    Pai, Madhukar
    Dheda, Keertan
    SCIENTIFIC REPORTS, 2018, 8
  • [30] Impact of nicotine replacement therapy as an adjunct to anti-tuberculosis treatment and behaviour change counselling in newly diagnosed pulmonary tuberculosis patients: an open-label, randomised controlled trial
    Surendra Kumar Sharma
    Alladi Mohan
    Achintya Dinesh Singh
    Hridesh Mishra
    Sonali Jhanjee
    Ravindra Mohan Pandey
    Binit Kumar Singh
    Rohini Sharma
    Prakash Babu Pallipamu
    Madhukar Pai
    Keertan Dheda
    Scientific Reports, 8